Stocks Health care QDEL
NASDAQ · Health careQuidelOrtho Corp (QDEL)
QuidelOrtho Corp brought in $2.6B of revenue over the twelve months to September 27, 2026, down 4.5% from a year earlier. It posted a net loss of $369.2M. In fiscal 2025 capital spending exceeded operating cash flow by $83M. At September 27, 2026 it held $166.4M in cash against $2.9B of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on November 4, 2026.
Key facts about QuidelOrtho Corp
- Net worth
- QuidelOrtho Corp has a market value (market cap) of $809.9M at the latest share price, and shareholders' equity of $1.8B on its balance sheet at September 27, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $2.7B (-1.9% year on year), with a net loss of $1.1B. Over the 12 months to September 27, 2026: revenue $2.6B, net loss $369.2M.
- Cash flow
- In fiscal 2025 operations brought in $105.2M of cash; after $188.2M of capital spending, free cash flow was -$83M.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on November 4, 2026 and covers the period to September 27, 2026. Open on SEC EDGAR
- Next earnings report
- QuidelOrtho Corp's next report is expected around February 10, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
What QuidelOrtho Corp does
QuidelOrtho Corp is registered with the SEC under industry code SIC 2835 (In Vitro & In Vivo Diagnostic Substances). Its shares trade on NASDAQ under the ticker QDEL.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $2.7B | -$1.1B | -$16.69 | -$83M |
| 2024 | $2.8B | -$2.1B | -$30.54 | -$112.1M |
| 2023 | $3B | -$10.1M | -$0.15 | $70.9M |
| 2022 | $3.3B | $548.7M | $9.56 | $744.4M |
| 2022 | $1.7B | $704.2M | $16.43 | $513.1M |
| 2020 | $1.7B | $810.3M | $18.60 | $564.8M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where QDEL ranks in Health care
Latest SEC filings
What QuidelOrtho Corp has filed recently, newest first. Each links to the original document on SEC EDGAR.
- November 4, 2026Quarterly report 10-Q · period to September 27, 2026Revenue fell 12% to $618.9M versus the same quarter last year; diluted EPS -$0.78 versus -$10.78.
- November 3, 2026
- October 7, 2026Passive stake changed SCHEDULE 13G/A
- September 23, 2026Material agreement8-KQuidelOrtho amended its credit agreement to obtain financial covenant relief through September 30, 2029.
- August 14, 2026Passive stake changed SCHEDULE 13G/A
- August 14, 2026Passive stake changed SCHEDULE 13G/A
- August 13, 2026Passive stake (5% or more) SCHEDULE 13G
- August 7, 2026Quarterly report 10-Q · period to June 28, 2026Revenue rose 2.8% to $630.9M versus the same quarter last year; diluted EPS -$1.36 versus -$3.77.
- August 6, 2026
- August 5, 2026Passive stake changed SCHEDULE 13G/A
Insider trades
What the people running QuidelOrtho Corp did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider bought or sold shares on the open market in the last 90 days. The 6 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| October 15, 2026 | Siegrist Jonathan PhilipEVP of R&D & CTO | Exercised options | 18,657 | - |
| October 15, 2026 | Siegrist Jonathan PhilipEVP of R&D & CTO | Shares withheld for tax | 6,695 | $93.1K |
| September 15, 2026 | Bowman Ronald LeeChief Human Resources Officer | Exercised options | 2,566 | - |
| September 15, 2026 | Bowman Ronald LeeChief Human Resources Officer | Shares withheld for tax | 921 | $9.8K |
| August 15, 2026 | Hanson Bryan MichaelEVP Global Port. Mgmt & Mkting | Exercised options | 446 | - |
| August 15, 2026 | Hanson Bryan MichaelEVP Global Port. Mgmt & Mkting | Shares withheld for tax | 162 | $2.3K |
| July 1, 2026 | Hanson Bryan MichaelEVP Global Port. Mgmt & Mkting | Exercised options | 5,797 | - |
| July 1, 2026 | Hanson Bryan MichaelEVP Global Port. Mgmt & Mkting | Shares withheld for tax | 2,096 | $38.1K |
Who owns QDEL
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Fmr LLC13G, passive with 1 related filers | 11.5% | May 7, 2026 |
| Newtyn Management, LLC13G, passive with 1 related filers | 9.7% | August 14, 2026 |
| Vanguard Portfolio Management13G, passive | 6% | April 29, 2026 |
| Rubric Capital Management LP13G, passive with 1 related filers | 5.56% | February 13, 2026 |
| Vanguard Capital Management13G, passive | 5.24% | April 30, 2026 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 244 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| BlackRock, Inc. | 11,202,523 | +753,396 |
| Fmr LLC | 7,363,696 | +772,544 |
| Newtyn Management, LLC | 6,625,000 | +2,066,528 |
| Vanguard Portfolio Management LLC | 4,135,464 | +103,696 |
| Neuberger Berman Group LLC | 3,534,619 | +2,004,205 |
| Invesco Ltd. | 3,473,432 | +355,963 |
| American Century Companies Inc | 3,307,079 | +450,947 |
| Rubric Capital Management LP | 3,306,281 | 0 |
| Vanguard Capital Management LLC | 3,070,054 | +17,344 |
| State Street Corp | 2,978,639 | +192,018 |
| Paradigm Capital Management Inc | 2,521,700 | +995,800 |
| Private Management Group Inc | 2,070,391 | +685,622 |
| Geode Capital Management, LLC | 1,834,237 | +119,038 |
| Morgan Stanley | 1,675,525 | +652,015 |
| Segall Bryant & Hamill, LLC | 1,345,530 | -197,880 |
| Dimensional Fund Advisors LP | 1,253,683 | -1,795,085 |
| Allianz Asset Management GmbH | 1,126,225 | +119,888 |
| Goldman Sachs Group Inc | 1,064,744 | -1,347,667 |
| Rice Hall James & Associates, LLC | 1,063,559 | +37,139 |
| Gagnon Securities LLC | 1,030,371 | +627,046 |
Insiders
17 insiders reported holding 551,965 shares in total, about $6.5M at the last price.
| Holder | Shares |
|---|---|
| Buechler Kenneth FDirector | 110,906 |
| Blaser Brian J.President and CEO | 75,72240,073 held indirectly |
| Busky Joseph M.Chief Financial Officer | 55,10810,290 held indirectly |
| Widder Kenneth JDirector | 45,073 |
| Hodges Michelle AChief Legal Officer | 41,605 |
| Strobeck MatthewDirector | 34,604 |
| Michael Edward L.Director | 29,433 |
| Siegrist Jonathan PhilipEVP of R&D & CTO | 25,381 |
| Rhoads Ann DDirector | 23,257 |
| McLellan Philip D.Chief Operations Officer | 22,497 |
Questions about QDEL
What does QuidelOrtho Corp do?
QuidelOrtho Corp is a company in the Health care sector, listed on NASDAQ as QDEL. Its shares trade on NASDAQ under the ticker QDEL.
What is QuidelOrtho Corp's net worth?
QuidelOrtho Corp has a market value (market cap) of $809.9M at the latest share price, and shareholders' equity of $1.8B on its balance sheet at September 27, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is QuidelOrtho Corp profitable?
No. Over the twelve months to September 27, 2026 it reported a net loss of $369.2M on revenue of $2.6B.
How much revenue does QuidelOrtho Corp make?
Over the twelve months to September 27, 2026 QuidelOrtho Corp reported revenue of $2.6B. That is 4.5% less than a year earlier.
When did QuidelOrtho Corp last report?
Its most recent periodic report is the quarterly report (10-Q) filed on November 4, 2026. It covers the period to September 27, 2026.
When is QuidelOrtho Corp's next earnings report?
QuidelOrtho Corp's next report is expected around February 10, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
Similar companies
Compare QDEL with
Follow QDEL
Get an email when QuidelOrtho Corp files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values QuidelOrtho Corp tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.